Targeting the A3 adenosine receptor for glaucoma treatment (Review)

Author：

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.7, Iss.6, 2013-01, pp. : 1723-1725

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature

Recent Patents on Anti-Cancer Drug Discovery, Vol. 13, Iss. 1, 2018-01 ,pp. : 40-69

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine acts as an inhibitor of lymphoma cell growth - a major role for the A3 adenosine receptor

By Fishman P. Bar-Yehuda S. Ohana G. Pathak S. Wasserman L. Barer F. Multani A.S.

European Journal of Cancer, Vol. 36, Iss. 11, 2000-07 ,pp. : 1452-1458

Elsevier

Access to resources Recommend Favorite

Targeting CD83 for the treatment of graft-versus-host disease (Review)

By Wang Xiongfei Wei Ming Q. Liu Xiaosong

Experimental and Therapeutic Medicine, Vol. 5, Iss. 6, 2013-06 ,pp. : 1545-1550

Spandidos Publications

Access to resources Recommend Favorite

Vasoactive intestinal peptide receptor-based imaging and treatment of tumors (Review)

International Journal of Oncology, Vol. 44, Iss. 4, 2014-01 ,pp. : 1023-1031

Spandidos Publications

Access to resources Recommend Favorite

siRNA targeting decoy receptor 3 enhances the sensitivity of gastric carcinoma cells to 5-fluorouracil

Experimental and Therapeutic Medicine, Vol. 4, Iss. 3, 2012-01 ,pp. : 465-468

Spandidos Publications

Access to resources Recommend Favorite